Future regenerative therapies will demand higher performance and shorter recovery times.

 

Theradaptive is shaping the future of regenerative medicine with a new platform to deliver therapeutics that promote targeted native tissue repair.

​

News

​

Theradaptive featured in BioCapital among top biotech startups on the rise.

​

Regenerative Medicine profile in BioBuzz.

​

Theradaptive Selected as a Finalist at the 2018 First Coast Innovation Challenge in Boston

​

Theradaptive selected for Phase II funding under the Defense Health Program Small Business Innovation Research Program to develop orthopedic repair implants with biologic delivery capability. 

​

Theradaptive partners on a $1.47M DoD Contract to develop next-gen 3D printed drug-eluting spinal fusion devices

​

​